Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Lifetime trauma may speed progression of HIV, early death

Lifetime trauma may speed progression of HIV, early death

November 02, 2007

CHAPEL HILL - Even though effective drug cocktails have improved the outlook for many patients with HIV, disease progression, including the time from AIDS onset to death, varies widely from patient to patient. Now, a study led by the University of North Carolina at Chapel Hill School of Medicine provides new evidence that psychological factors play a role in disease progression.

The study is the first-known in the era of highly active antiretroviral therapy (HAART) for HIV to show that traumatic life events, such as physical or sexual abuse, are associated with faster mortality, both from AIDS-related and all causes.




"Trauma and depression are common among people with HIV, and trauma and depression seem to have an effect on disease progression and mortality in HIV. Given that, it is critical that clinicians treating people infected with HIV recognize depression and trauma as risk factors for poor health outcomes, and thus screen and refer patients for psychological and psychiatric treatment when these problems are present," said Jane Leserman, Ph.D., professor of psychiatry and medicine and lead author of the study.

"Some combination of cognitive behavioral therapy and medication might be very beneficial for patients experiencing severe or multiple types of trauma," Leserman said.

The study is published in the Nov. 1, 2007 edition of the American Journal of Psychiatry.

The researchers interviewed a group of 490 HIV infected patients in the rural southeast. Those who reported a greater number of categories of traumatic life events had faster death from all causes and from AIDS. More than half of the patients in the study experienced three or more lifetime traumas, and half had experienced physical or sexual abuse.

Unlike depression, the effects of which have been more widely studied in the era of HAART, with trauma, it's possible to establish a time ordering of events.

"In our study, these traumatic events occurred in most cases many years before the progression of the patients' HIV. So it's a more compelling argument for a causal effect of trauma," Leserman said. "Trauma, most of it occurring two or more years before the study, seemed to continue to have a major impact on these patients."

Leserman hopes to study whether treating HIV patients for trauma results in better health outcomes. "We need further study of trauma treatment in this population to find out if that attenuates some of the negative effects," she said.

University of North Carolina at Chapel Hill



Related Disease Progression Current Events and Disease Progression News Articles Disease Progression Current Events and Disease Progression News RSS Disease Progression Current Events and Disease Progression News RSS
Researchers find potential treatment for Huntington's disease
Investigators at Burnham Institute for Medical Research (Burnham), the University of British Columbia's Centre for Molecular Medicine and Therapeutics and the University of California, San Diego have found that normal synaptic activity in nerve cells (the electrical activity in the brain that allows nerve cells to communicate with one another) protects the brain from the misfolded proteins associated with Huntington's disease.

New Notre Dame study provides insights into the molecular basis of tumor cell behavior
A new study by a team of researchers led by Crislyn D'Souza-Schorey, associate professor of biological sciences at the University of Notre Dame, sheds light on the molecular basis by which tumor cells modulate their surroundings to favor cancer progression.

Widely used cholesterol-lowering drug may prevent progression
Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease.

Surgeons at Boston Medical Center offering new procedure for acid reflux/GERD
Boston Medical Center (BMC) surgeons are now offering patients an incisionless alternative to laparoscopic and traditional surgery for treatment of acid reflux or GERD.

Neurologists Investigate Possible New Underlying Cause of MS
Neurologists at the University at Buffalo are beginning a research study that could overturn the prevailing wisdom on the cause of multiple sclerosis (MS).

Radiologists develop scale to help clinicians predict disease severity in infants with NEC
Radiologists at Duke University Medical Center have developed a scale called the Duke Abdominal Assessment Scale (DAAS) to assist clinicians in determining the severity of disease and the need for surgery in infants with necrotizing enterocolitis (NEC).

Compound shows potential for slowing progression of ALS
A chemical cousin of a drug currently used to treat sepsis dramatically slows the progression of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, in mice.

U-M researchers find those with severe H1N1 at risk for pulmonary emboli
University of Michigan researchers have found that patients with severe cases of the H1N1 virus are at risk for developing severe complications, including pulmonary emboli, according to a study published today in the American Journal of Roentgenology.

Urate in blood and spinal fluid may predict slower decline in patients with Parkinson's disease
Higher concentration of urate (an antioxidant) in the blood and spinal fluid of patients with early Parkinson's disease is associated with slower rates of clinical decline.

Study supports possible role of urate in slowing Parkinson's disease progression
By examining data from a 20-year-old clinical trial, a research team based at the MassGeneral Institute for Neurodegenerative Diseases (MGH-MIND) and Harvard School of Public Health (HSPH), has found evidence supporting the findings of their 2008 study - that elevated levels of the antioxidant urate may slow the progression of Parkinson's disease.
More Disease Progression Current Events and Disease Progression News Articles
  Lung and Paranasal Sinuses: the Beginnings and Progression of Disease with the Influence of Allergy and Infection
by William W Wasson (Author)



Juiced

Juiced
Also With: FOX (Producer)



Progression of Parkinson's Disease

Progression of Parkinson's Disease
Parkinson's Answers (Primary Contributor)



Acoustic characteristics of Parkinsonian speech: a potential biomarker of early disease progression and treatment [An article from: Journal of Neurolinguistics]

Acoustic characteristics of Parkinsonian speech: a potential biomarker of early disease progression and treatment [An article from: Journal of Neurolinguistics]
by B.T. Harel (Author), M.S. Cannizzaro (Author), H. Cohen (Author), N. Reilly (Author)

This digital document is a journal article from Journal of Neurolinguistics, published by Elsevier in 2004. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.

Description:
One of the frequent signs of Parkinson's disease (PD) is the presence of a progressive hypokinetic dysarthria. Numerous studies have since documented speech motor impairment, but attempts at quantifying any such changes longitudinally throughout the early course of the disease have been rare. In this study, a retrospective analysis of speech was conducted on two well-known individuals with PD and two matched controls to determine if certain acoustic measures were sensitive markers of early pathophysiologic...

  Statins fail to slow kidney disease progression.(Clinical Rounds)(Clinical report): An article from: Family Practice News
by Nancy Walsh (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on December 15, 2008. The length of the article is 694 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Statins fail to slow kidney disease progression.(Clinical Rounds)(Clinical report)
Author: Nancy Walsh
Publication: Family Practice News (Magazine/Journal)
Date: December 15, 2008
Publisher: International Medical News Group
Volume: 38 Issue: 24 Page: 31(1)

Article Type: Clinical report

Distributed by Gale, a part of Cengage...

Not Alone in the World: Caring for Someone with Alzheimer's Disease

Not Alone in the World: Caring for Someone with Alzheimer's Disease
Also With: Medcom Trainex (Primary Contributor), Dr. James Kvale (Primary Contributor), Mary Barringer (Primary Contributor)

Outlines both the physiological and psychological progression of Alzheimer's disease and its effects not only on the patient, but also on the caregiver. Illustrates safety measures and practical coping techniques. Adult day care programs are discussed and shown.

  Omega-3 fatty acid capsules reduce endothelial dysfunction in hyperlipidemia: slow coronary heart disease progression?(News): An article from: Pediatric News
by Bruce Jancin (Author)

This digital document is an article from Pediatric News, published by International Medical News Group on September 1, 2003. The length of the article is 446 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Omega-3 fatty acid capsules reduce endothelial dysfunction in hyperlipidemia: slow coronary heart disease progression?(News)
Author: Bruce Jancin
Publication: Pediatric News (Magazine/Journal)
Date: September 1, 2003
Publisher: International Medical News Group
Volume: 37 Issue: 9 Page: 5(1)

Distributed by Thomson...

Cancer: Disease Progression and Chemoprevention 2007

Cancer: Disease Progression and Chemoprevention 2007
by Edited by Takuji Tanaka (Author)

From the Preface

Dramatic advances in our understanding of cancer development have come from epidemiologic and laboratory animal research. The critical events occur during the early stages of the dynamic multi-step process leading to invasive cancer. Such emerging knowledge will provide further insights not only into carcinogenic processes, but also into more sensitive methods of early detection and more effective means of prevention.

In this book, we have succeeded in preparing a comprehensive, timely, and critical review of the substantial progress that has been made in our understanding of cancers, their precursors, and inhibition of these. They have enlisted experts in the field, who have contributed authoritative chapters, on the precursors to a wide variety of cancers, with...

  High-dose atorvastatin may slow the progression of Alzheimer's disease.(Geriatric Medicine): An article from: Family Practice News
by Bruce Jancin (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on February 1, 2005. The length of the article is 589 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: High-dose atorvastatin may slow the progression of Alzheimer's disease.(Geriatric Medicine)
Author: Bruce Jancin
Publication: Family Practice News (Magazine/Journal)
Date: February 1, 2005
Publisher: International Medical News Group
Volume: 35 Issue: 3 Page: 75(1)

Distributed by Thomson...

  Take proactive measures to reduce kidney disease complications: prevent progression of kidney disease by controlling blood pressure and blood glucose levels ... An article from: Women's Health Advisor
by Unavailable (Author)

This digital document is an article from Women's Health Advisor, published by Belvoir Media Group, LLC on August 1, 2009. The length of the article is 656 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Take proactive measures to reduce kidney disease complications: prevent progression of kidney disease by controlling blood pressure and blood glucose levels and exercising regularly.(RENAL HEALTH)
Author: Unavailable
Publication: Women's Health Advisor (Magazine/Journal)
Date: August 1, 2009
Publisher: Belvoir Media Group, LLC
Volume: 13 Issue: 8 Page: 5(1)

Distributed by Gale, a part of...

© 2009 BrightSurf.com